Chronic Myeloid Leukemia | Treatment Sequencing | US | 2017

Publish date: September 2017

Login to access report

Treatment Sequencing provides disease-specific, sequential treatment patterns in market-relevant treatment scenarios and drug share mapped to treatment journey. The quantitative sequencing analysis illuminates drug positioning through primary market research-based insights from physicians and DRG oncology experts’ assumptions.